The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancer
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0314564 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Kyukwang Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Signal Transduction, WAP Four-Disulfide Core Domain Protein 2, NF-kappa B. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ovarian cancer is the leading cause of death among gynecologic malignancies. Despite recent advancements in targeted therapies such as PARP inhibitors, recurrence is common and frequently resistant to existing therapies. A powerful diagnostic tool, coupled with a comprehensive understanding of its implications, is crucial. HE4, a clinical serum biomarker for ovarian cancer, has shown efficacy in monitoring malignant phenotypes, yet little is known about its biological role and regulatory mechanisms. Our research demonstrates that HE4 expression in ovarian cancer can be regulated by the NF-κB signaling pathway. We found that the activation of NF-κB signaling by tumor necrosis factor (TNF)-α, a cytokine found in ovarian cancer tumors and ascites, enhanced the secretion of HE4 while its inhibition suppressed HE4 levels. Nuclear translocation of the NF-κB component p65 was found to be critical for HE4 expression; induced NF-κB activation through p65 expression or constitutive IKK2 activity elevated HE4 expression, while p65 knockdown had the opposite effect. Furthermore, we observed that NF-κB mediated HE4 expression at the transcriptional level. Our data also suggests that there is a regulatory role for HE4 in the expression of α 5 -Integrin, a crucial adhesion molecule in ovarian cancer metastasis; HE4 knockdown corresponded with reduced α 5 -Integrin expression, cell migration and cell adhesion to fibronectin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, United States of America.
- Department of Microbiology and Immunology, University of Rochester, Rochester, NY, United States of America.
ORCID-Profile: Kyukwang Kim, John P Miller
Zitieren
APA
Kim, K., Khazan, N., McDowell, J. L., Snyder, C. W. A., Miller, J. P., Singh, R. K., Whittum, M. E., Turner, R., & Moore, R. G. (2024). The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancer. PLOS ONE. https://doi.org/10.1371/journal.pone.0314564
Vancouver
Kim K, Khazan N, McDowell JL, Snyder CWA, Miller JP, Singh RK, et al. The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancer. PLOS ONE. 2024. doi:10.1371/journal.pone.0314564
BibTeX
@article{Kim2024,
author = {Kim, Kyukwang and Khazan, Negar and McDowell, Jamie L and Snyder, Cameron W A and Miller, John P and Singh, Rakesh K and Whittum, Michelle E and Turner, Rachael and Moore, Richard G},
title = {The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancer},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0314564}
}
EUVIMED